Wipperman, Matthew F. http://orcid.org/0000-0003-1436-3366
Bhattarai, Shakti K.
Vorkas, Charles Kyriakos http://orcid.org/0000-0003-4952-7041
Maringati, Venkata Suhas
Taur, Ying http://orcid.org/0000-0002-6601-8284
Mathurin, Laurent
McAulay, Katherine
Vilbrun, Stalz Charles
Francois, Daphie
Bean, James
Walsh, Kathleen F. http://orcid.org/0000-0002-9001-3918
Nathan, Carl
Fitzgerald, Daniel W.
Glickman, Michael S. http://orcid.org/0000-0001-7918-5164
Bucci, Vanni http://orcid.org/0000-0002-3257-2922
Article History
Received: 24 July 2020
Accepted: 21 January 2021
First Online: 18 February 2021
Competing interests
: M.F.W. is currently an employee and shareholder of Regeneron Pharmaceuticals, Inc. M.S.G. reports consulting fees and equity in Vedanta Biosciences, Inc., consulting fees from Takeda, and is on the SAB of PRL-NYC. V.B. is supported by a Sponsored Research Agreement from Vedanta Biosciences, Inc. The remaining authors declare no competing interests.